Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions

Binaifer R. Balsara, Jianming Pei, Yasuhiro Mitsuuchi, Robert Page, Andres Klein-Szanto, Hao Wang, Michael Unger, Joseph R. Testa

Research output: Contribution to journalArticle

Abstract

AKT is frequently activated in various cancers, but its involvement in lung tumor development and progression is not well established. We examined AKT activity by immunohistochemistry in 110 non-small cell lung carcinomas (NSCLCs) using tissue microarrays. AKT activation was observed in 56 (51%) tumors. To further validate activation of the AKT pathway in this series, we examined the phosphorylation status of the mammalian target of rapamycin (mTOR) and forkhead (FKHR), two down-stream targets of AKT. Positive staining for phospho-mTOR and phospho-FKHR were detected in 74% and 68% of tumors, respectively, and was significantly associated with activation of AKT. Tumors positive for phosphorylated (active) AKT were present with a similar frequency in low stage (I/II) and high stage (II/IV) tumors, raising the possibility that AKT activation occurs early in tumor progression. We therefore examined AKT activity in 25 bronchial epithelial lesions from 12 patients at high risk of lung cancer. Metaplastic/dysplastic areas showed AKT activity, whereas normal and hyperplastic bronchial epithelia exhibited little or no activity. Since some bronchial epithelial lesions may develop into invasive cancers, we examined the effect of AKT on invasiveness of lung cancer cells, using an in vitro cell invasion assay. Transfection of NSCLC cells with wild-type AKT increased invasiveness in response to hepatocyte growth factor, whereas transfection with dominant negative AKT abrogated this effect. Collectively, these data suggest that AKT activation is a frequent and early event in lung tumorigenesis, which may enhance risk of progression to malignancy. Thus, AKT represents a potentially important target for chemoprevention in individuals at high risk of NSCLC.

Original languageEnglish (US)
Pages (from-to)2053-2059
Number of pages7
JournalCarcinogenesis
Volume25
Issue number11
DOIs
StatePublished - Nov 1 2004

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions'. Together they form a unique fingerprint.

  • Cite this

    Balsara, B. R., Pei, J., Mitsuuchi, Y., Page, R., Klein-Szanto, A., Wang, H., Unger, M., & Testa, J. R. (2004). Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis, 25(11), 2053-2059. https://doi.org/10.1093/carcin/bgh226